Deal Details
Convertible Senior Notes
Summary
Baird served as a co-manager in this offering
About
Affymetrix, Inc. (“Affymetrix” or the “Company”) (NasdaqGS: AFFX) recently priced an offering of $105 million aggregate principal amount of unsecured 4.00% Convertible Senior Notes due 2019. The Company intends to use the net proceeds from the offering to fund a portion of the purchase price for its acquisition of eBioscience Holding Company, Inc.Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and nonprofit research institutes. More than 2,200 systems have been shipped around the world and almost 25,000 peer-reviewed papers have been published using the technology. Affymetrix is headquartered in Santa Clara, California and has manufacturing facilities in Cleveland, Ohio and Singapore. The Company has about 900 employees worldwide and maintains sales and distribution operations across Europe, Asia and Latin America.
For additional information about this transaction, please contact:
- Date
- June 2012
- Company
- Affymetrix, Inc.
- Transaction
- M&A
- Sectors
- Healthcare
- Target Geography
- North America
Share
